Forecast & Rating7 analysts currently cover VeraDermics, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $163.50, about 51.1% upside from the current price of $108.22. Price targets span a fair range, indicating some disagreement among institutions. For you, this means most professionals who study VeraDermics closely still see room for the stock to rise. Data as of Aug 13, 2026; for reference only and not investment advice.
Aug 13, 2026Price forecast
$163.5051.08%
Forecast & RatingStrong buy
7analysts
- Strong buy85.71%
- Buy14.29%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met55.2%
Stock price$108.22
Avg. target$163.5
High target$182
Low target$135
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.